International Patent: METHODS FOR GENERATING CONSENSUS SEQUENCE THAT PERMITS OPTIMIZED PRIMER DESIGN

GENEVA, Aug. 21 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/014664) for “METHODS FOR GENERATING CONSENSUS SEQUENCE THAT PERMITS OPTIMIZED PRIMER DESIGN”. With publication no. WO/2026/173872, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 25/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....